2004Practical Preventive MedicineRequires access

The Susceptibility of Ureaplasma Urealyticum to Fluoroquinolones

Zhang Wen-b

Open publisher page 0 citations

Abstract

Objective To test the susceptibility of clinical Uu isolates from Hengyang area to fluoroquinolone and provide an experimental data for clinical chemotherapy. Method Broth microdilution method was used for susceptibility testing of 86 isolates of Uu to six fluoroquinolones. Results Among six fluoroquinolones, Sparfloxacin and Gatifloxacin were the most active against Uu, with MIC50 being 0.25 μg/ml and 0.5 μg/ml, respectively, with MIC90 being 4 μg/ml for both. Levofloxacin and Ofloxacin were less active, with MIC50 being 1 μg/ml, 2 μg/ml and MIC90 being 4 μg/ml, 8 μg/ml, respectively. Norfloxacin and Ciprofloxacin had the least activity against Uu. Conclusions New fluoroquinolone such as Sparfloxacin, Levofloxacin and Gatifloxacin show greater activity against Uu than the older agents do; Uu is resistant to older fluoroquinolones in varing degrees.

About this research paper

What this paper is about

Objective To test the susceptibility of clinical Uu isolates from Hengyang area to fluoroquinolone and provide an experimental data for clinical chemotherapy. Method Broth microdilution method was used for susceptibility testing of 86 isolates of Uu to six fluoroquinolones. Results Among six fluoroquinolones, Sparfloxacin and Gatifloxacin were the most active against Uu, with MIC50 being 0.25 μg/ml and 0.5 μg/ml, respectively, with MIC90 being 4 μg/ml for both. Levofloxacin and Ofloxacin were less active, with MIC50 being 1 μg/ml, 2 μg/ml and MIC90 being 4 μg/ml, 8 μg/ml, respectively. Norfloxacin and Ciprofloxacin had the least activity against Uu. Conclusions New fluoroquinolone such as Sparfloxacin, Levofloxacin and Gatifloxacin show greater activity against Uu than the older agents do; Uu is resistant to older fluoroquinolones in varing degrees.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To test the susceptibility of clinical Uu isolates from Hengyang area to fluoroquinolone and provide an experimental data for clinical chemotherapy. Method Broth microdilution method was used for susceptibility testing of 86 isolates of Uu to six fluoroquinolones. Results Among six fluoroquinolones, Sparfloxacin and Gatifloxacin were the most active against Uu, with MIC50 being 0.25 μg/ml and 0.5 μg/ml, respectively, with MIC90 being 4 μg/ml for both. Levofloxacin and Ofloxacin were less active, with MIC50 being 1 μg/ml, 2 μg/ml and MIC90 being 4 μg/ml, 8 μg/ml, respectively. Norfloxacin and Ciprofloxacin had the least activity against Uu. Conclusions New fluoroquinolone such as Sparfloxacin, Levofloxacin and Gatifloxacin show greater activity against Uu than the older agents do; Uu is resistant to older fluoroquinolones in varing degrees.

Key concepts: Sparfloxacin, Gatifloxacin, Ofloxacin, Levofloxacin, Norfloxacin, Ureaplasma urealyticum, Broth microdilution, Ciprofloxacin

Related papers

Back to paper searchBrowse research topicsOriginal source
The Susceptibility of Ureaplasma Urealyticum to Fluoroquinolones — Research Paper | ScholarLens